Drug Approval | February 22, 2022
UK MHRA approves Marksans All in One oral solution
Therapeutic use of the product is for short term symptomatic relief of colds, chills and influenza including chesty coughs
Therapeutic use of the product is for short term symptomatic relief of colds, chills and influenza including chesty coughs
Merck is studying the Complete Response Letter and it is not related to the safety of gefapixant
The company has been manufacturing masks since the Covid-19 outbreak in 2020
Yoga helps to build a strong immune system and daily breathing regime of 10-minute helps in the long run
Ind-Ra expects revenue growth of over 12% in 2022.
Patient with acute Covid-19 infection treated at BGS Gleneagles Global Hospital
The offline store launch will complement the E-commerce website in building a rich consumer shopping experience
Rad-G is a rugged, portable, handheld Masimo SET Measure-through Motion and Low Perfusion pulse oximeter and noninvasive respiration rate monitor
This test is inexpensive and results are available immediately as compared to the genetic test
Dupixent is the only biologic medicine to improve lung function in children aged 6 to 11 years in a randomized Phase 3 trial, supporting potential as a best-in-class option
Subscribe To Our Newsletter & Stay Updated
